FDA approves breakthrough cancer gene test
FDA approves breakthrough cancer gene testFDA approved a new cancer biomarker test that can detect genetic mutations in 324 genes and 2 genomic signatures in tumors.
Six diseases reap benefits of biomarkers, genetic tests
Six diseases reap benefits of biomarkers, genetic testsBiomarker testing for harmful genetic mutations provides the opportunity to identify at-risk individuals who might benefit from risk modification strategies and/or enhanced disease screening.
Genetic testing: Two downsides to considerGenetic testing holds great promise, but there are some critical drawbacks to consider.
New biomarker may predict treatment response in DMEResearchers have identified a new biomarker they believe can be used as a predictor of vision change in patients with diabetic macular edema, either during the natural history of the disease or after undergoing anti-VEGF therapy. The biomarker is disorganization of the retinal inner layers, or DRIL.
4 biomarkers may improve Sjögren's syndrome treatmentResearch on the composition of tears and their secretory processes is generating insights that may lead to earlier detection and treatment of Sjögren’s syndrome.
Glaucoma cure may be found in newly discovered biomarkersThe study of biomarkers for glaucoma is pointing to promising avenues for new treatments, according to Vivek J. Srinivasan, PhD.
AMCP: Include biomarker testing in coverage decisionsMore than 2,000 biomarker tests are available, and the NCCN Biomarkers Compendium contains information designed to support decision-making around the use of such testing in patients with cancer
Biomarker signals deadly NEC in preemiesResearchers have discovered a reliable biomarker for necrotizing enterocolitis (NEC), a potentially deadly bowel infection that affects primarily extremely low-birth-weight (LBW) infants.
Pediatric nonalcoholic fatty liver diseaseNonalcoholic fatty liver disease (NAFLD) in children is increasing, with studies showing it to be the most common liver abnormality in children aged 2 to 19 years.
Genetic variants linked to lower urinary tract symptoms in African-AmericansIn a study of African-American men, researchers say they’ve linked two genetic variants to severity of lower urinary tract symptoms related to BPH, giving scientists insight into the higher risk facing African-Americans.